Turner Investments’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Turner Investments’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-55,540	Closed	-$498K	–	314
2016 Q3	$498K	Sell	55,540 -121,990	-69%	-$867K	0.16%	143
2016 Q2	$953K	Buy	177,530 +16,430	+10%	+$84.2K	0.3%	100
2016 Q1	$741K	Buy	+161,100	New	+$648K	0.2%	134
2015 Q3	–	Sell	-40,010	Closed	-$632K	–	336
2015 Q2	$632K	Buy	+40,010	New	+$486K	0.12%	209

Turner Investments's RPTP Position: Q4 2016 in Review

Turner Investments sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 55,540 shares — an estimated $498K sold.

Turner Investments first reported a position in RPTP in Q2 2015 and held it in 4 quarters. The position peaked at $953K in Q2 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Turner Investments reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Turner Investments sold 55,540 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $498K.
Turner Investments first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2015 and held it in 4 quarters.
Turner Investments's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $953K in Q2 2016.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.